title: PTEN polymorphism (IVS4) is not associated with risk of prostate cancer.
authors.affiliation: Lank Center for Genitourinary Oncology, Department of Adult Oncology, Dana-Farber Cancer Institute, Boston MA 02115, USA.
authors.forename: D J
authors.initials: DJ
authors.lastname: George
authors.forename: T F
authors.initials: TF
authors.lastname: Shepard
authors.forename: J
authors.initials: J
authors.lastname: Ma
authors.forename: E
authors.initials: E
authors.lastname: Giovannucci
authors.forename: P W
authors.initials: PW
authors.lastname: Kantoff
authors.forename: M J
authors.initials: MJ
authors.lastname: Stampfer
mesh_terms: D000328:Adult; D016147:Genes, Tumor Suppressor / Q000235:genetics*; D018095:Germ-Line Mutation; D006801:Humans; D008297:Male; D051059:PTEN Phosphohydrolase; D010744:Phosphoric Monoester Hydrolases / Q000235:genetics*; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic; D011471:Prostatic Neoplasms / Q000209:etiology / Q000235:genetics*; D012307:Risk Factors; D025521:Tumor Suppressor Proteins
chemical_list: D025521:Tumor Suppressor Proteins; D010744:Phosphoric Monoester Hydrolases; D051059:PTEN Phosphohydrolase; C494929:PTEN protein, human